In 2008, leaders in the congenital muscular dystrophy (CMD) community began discussing the need for a new kind of resource that would connect and serve the needs of the entire congenital muscle disease community. What they envisioned was a central hub that would bring together those living with the disease, along with their families, friends and caregivers, to connect them with medical research, clinical care, clinical trials and each other.
At the same time, it would be a resource for industries with an interest in congenital muscle disease, allowing limited access to a database of information provided by patients and their families—information that could prove vital to advances in care and treatment. This resource would help connect these stakeholders, while providing them with resources never before available in one place. Today, the result of this endeavor is the CMDIR, a robust and cutting-edge website and registry.
Who We Are
The CMDIR is the only global registry for congenital muscle disease (CMD) with one goal, to achieve global registration of the CMD community. The CMDIR is a central hub for up to date information regarding CMD clinical studies and trials. Through the CMDIR, the CMD community has a home- a place to register with and without genetic confirmation of disease and a means by which to be contacted for clinical news.
The organizers of the CMDIR come from leaders in the non-profit sector and academic institutions. Regardless of their individual backgrounds, the CMDIR thought leaders share a common goal to increase the community’s ability to help one another through improved communication, and by doing so, to help those affected by congenital muscular dystrophy (CMD).
The information provided on the CMDIR has been developed with the review, direction and advice from a group of experts in congenital muscular dystrophy. Advisors contribute to CMDIR in many areas including reviewing educational materials, providing programmatic direction, advising on processes and procedures, and facilitating opportunities for outreach and collaboration.
The operations team behind this incredible resource continues to refine and perfect the site so that it evolves to best serve the needs of the entire community. We are open to your suggestions and feedback.
CMDIR Governing Board:
- Cure CMD, www.curecmd.org
- Joshua Frase Foundation, www.joshuafrase.org
- A Foundation Building Strength, www.buildingstrength.org
- TREAT-NMD, www.treat-nmd.eu
- S.A.M. (Struggle Against Muscular Dystrophy), www.helpsam.info
- Prevention Genetics, www.preventiongenetics.com
- Emory Genetics Lab, Department of Human Genetics
- Muscular Dystrophy Campaign, United Kingdom, www.muscular-dystrophy.org
- Muscular Dystrophy Association, Australia
- Association Francaise Contre Les Myopathies (AFM), France, www.afm-france.org/afm-english_version/
CMDIR Operations Team
- Anne Rutkowski, MD, CMDIR Director
- Rachel Alvarez, CMDIR Associate Director
- Elizabeth Dechene, MS, CGC, CMDIR Genetic Counselor
- Sarah Barnett, MS, CGC, CMDIR Genetic Counselor
- Sabine de Chastonay, PhD, Research Associate
- Emily Pinho, RN, Research Associate
- Scott Wong, Research Associate
- Janet Young, Outreach & Data Coordination
- Camila Taylor, Outreach & Data Coordination
- Benjamin Kaveladze, Data Coordination
- Anabel Jimenez, Data Coordination
- Kyle Brown, CEO & Founder, Patient Crossroads Rare Disease Patient Registries
- Jud Rhode, CTO & Co-Founder, Patient Crossroads Rare Disease Patient Registries
CMDIR Advisory Board
- Alan Beggs, PhD, Department of Pediatrics, Harvard University, Boston, Massachusetts
- Carsten Bonnemann, MD, PhD, NINDS Clinic- Congenital Muscle Disease, Bethesda, Maryland
- Susan Sparks, MD, PhD, Carolinas Medical Center, North Carolina
- Jiri Vajsar, MD, Hospital for Sick Kids, Toronto, Canada